3 結果
The investigation of the hydrolysed aqueous methanolic extract from the leaves of PHYTOLACCA ACINOSA Roxb. resulted in the isolation of phytolaccagenin ( 1) besides a new pentacyclic triterpenoid which was identified as 2beta,3beta-dihydroxy-23,30-dimethoxycarbonyl-28-carboxy-olean-12-ene =
Phytolacca acinosa is an herb for treatment of ascites and tumor. Two forms of phytolacca acinosa, i.e. raw and vinegar-processed herb, have been used in clinic. However, pharmacokinetic difference between the two forms of phytolacca acinosa has not been fully understood. Herein, a comparative
Radix Phytolaccae (the dried root of Phytolacca acinosa Roxb. or Phytolacca americana L.) is widely used in East Asian countries for the treatment of inflammation-related diseases. The active component of Radix Phtolaccae is Phytolcaccagenin a triterpenoid saponin. Phytolcaccagenin has